Biological actions of cleaved atrial natriuretic factor (ANF101-105/106-126) in conscious sheep.
Atrial natriuretic factor (ANF) cleaved between Cys105 and Phe106 is the primary metabolite of ANF and circulates in human plasma. Because the role of this metabolite in vivo and its possible interaction with intact ANF are unclear, we studied the biologic effects of a 2-h infusion of rat cleaved ANF101-105/106-126 (15 pmol/kg/min) or vehicle alone in six normal sheep. Infusions of cleaved ANF increased venous plasma levels of cleaved ANF from less than 5 to 260 pmol/L and induced a progressive and significant increase in plasma cyclic GMP (p = 0.025) without significantly affecting plasma ANF levels. These changes were associated with a small (nonsignificant) decrease in arterial pressure and a significant increase in heart rate (HR) and sympathetic nervous activity and were followed by activation of the renin-angiotensin-aldosterone (RAA) axis after infusions were terminated. Unlike ANF itself, cleaved ANF was not natriuretic and did not reduce plasma volume or right atrial pressure. Calculated metabolic clearance rate (MCR) (1.47 +/- 0.4 L/min) and disappearance rate of cleaved ANF from plasma (4.8 +/- 0.37 min) were similar to values reported previously for intact ANF in sheep. These studies show that cleaved ANF stimulates guanylate cyclase and alters hemodynamics and the RAA system in vivo.
Charles
C J
CJ
Department of Endocrinology, Princess Margaret Hospital, Christchurch, New Zealand.
Espiner
E A
EA
Yandle
T G
TG
Cameron
V A
VA
Richards
A M
AM
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D006152:Cyclic GMP / Q000097:blood; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006728:Hormones / Q000097:blood; D007668:Kidney / Q000187:drug effects; D010446:Peptide Fragments / Q000494:pharmacology*; D012084:Renin-Angiotensin System / Q000187:drug effects; D012756:Sheep
D006728:Hormones; D010446:Peptide Fragments; D009320:Atrial Natriuretic Factor; D006152:Cyclic GMP